We’ve all recently experienced how important it is to get new medicines and vaccines into the clinic quickly, but don’t let anyone tell you that drug development is easy. The path of getting a drug to the clinic is often filled with speed bumps and obstacles your program needs to navigate. However, this journey can be made much easier with the proper guidance.
Join our panel of experts as they discuss:
- Common areas to focus on when planning to enter first-in-human clinical trials
- Why understanding scientific and regulatory requirements will benefit your preclinical program
- Prior cases demonstrating common mistakes and best practices
Peter Gaskin, PhD, ERT, MTOPRA
Senior Director, Scientific Advisory Services
Balázs Tóth, PhD
Manu Kohli, PhD
Principal Scientific Advisor
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.